MedPath

angerhans cell histiocytosis (LCH): treatment protocol of the first international study

Completed
Conditions
ymphoma (non-Hodgkin's)
Cancer
Langerhans cell histiocytosis (LCH)
Registration Number
ISRCTN97375227
Lead Sponsor
Cancer Research UK (CRUK) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Definitive diagnosis of multi-system Langerhans cell histocytosis
2. Age under 18 years
3. No prior treatment for Langerhans cell histocytosis

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ot provided at time of registration
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath